Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Gabapentin NDC 50090-2561 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - image 1

1 - image 1

The text represents an equation to calculate cLcr (creatinine clearance) for male patients and female patients. The equation takes into account the patient's age and weight in kilograms, and the serum creatinine level in milligrams per deciliter.*

1 - image 2

1 - image 2

1 - image 3

1 - image 3

1 - image 4

1 - image 4

1 - image 5

1 - image 5

1 - image 6

1 - image 6

This appears to be a chart or graph displaying the mean pain score for a study that involved a dose titration period followed by a 4-week fixed dose period. The two treatment options indicated are a placebo and a dosage of gabapentin at 3600 mg/day. There is also a baseline measurement period and the duration of the study is indicated as being multiple weeks. No further information is available.*

2 - image 7

2 - image 7

This appears to be a chart or table related to pain management. It includes information on mean pain score and different dosages of Gabapentin administered over a fixed period of four weeks. However, without further context or information, it is difficult to provide a full description of the purpose or significance of this data.*

3 - image 8

3 - image 8

4 - image 9

4 - image 9

Label Image - lbl500902561

Label Image - lbl500902561

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.